Nickoloff B J, Mitra R S
Department of Pathology, University of Michigan Medical Center, Ann Arbor.
J Invest Dermatol. 1989 Dec;93(6):799-803. doi: 10.1111/1523-1747.ep12284427.
The growth of cultured human keratinocytes (KC) is inhibited by gamma interferon (IFN-gamma), cyclosporin A and transforming growth factor-beta, but not by tumor necrosis factor. When these antiproliferative molecules were added to KC they induced a concentration and time-dependent inhibition of 125I-epidermal growth factor (I-EGF) binding. These anti-proliferative molecules primarily reduced the number of binding sites by approximately 25%-50% without affecting the binding affinity. Tumor necrosis factor did not influence the ligand binding by I-EGF. In parallel with the ability of the antiproliferative molecules to inhibit I-EGF binding, there was an increase in transforming growth factor-alpha production. These results suggest that several different antiproliferative molecules may share a common mechanism to inhibit cell growth by reducing I-EGF binding to KC.
培养的人角质形成细胞(KC)的生长受到γ干扰素(IFN-γ)、环孢菌素A和转化生长因子-β的抑制,但不受肿瘤坏死因子的抑制。当将这些抗增殖分子添加到KC中时,它们会诱导对125I-表皮生长因子(I-EGF)结合的浓度和时间依赖性抑制。这些抗增殖分子主要使结合位点数量减少约25%-50%,而不影响结合亲和力。肿瘤坏死因子不影响I-EGF的配体结合。与抗增殖分子抑制I-EGF结合的能力平行,转化生长因子-α的产生增加。这些结果表明,几种不同的抗增殖分子可能通过减少I-EGF与KC的结合而共享一种抑制细胞生长的共同机制。